Covaxin Found To Be 77.8% Effective Against Covid In Lancet Study

PUBLISHED ON: November 12, 2021 | Duration: 1 min, 20 sec

facebooktwitteremailkoo
loading..
Covaxin, a vaccine developed by government's medical research agency and Bharat Biotech International Ltd., was found to have a 77.8% efficacy rate against symptomatic Covid-19 in a long-awaited analysis published in The Lancet.
ALSO WATCH
World's 1st Covid Nasal Vaccine Out On Republic Day

................................ Advertisement ................................

Short videosBy Firework

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com